12/02/2026 16:03
Morgan Stanley raised the target price for WuXi Bio (02269) to HKD50 from HKD45 and maintained the "overweight" rating.
The research house said it raises 2026-30 earnings estimates by 4-10% on accelerating revenue growth and margin expansion.
【香港好去處】2026去邊最好玩？etnet為你提供全港最齊盛事活動，所有資訊盡在掌握！► 即睇
上一篇新聞︰13/02/2026 14:49 {I-bank focus}BofA lowers Lenovo Group (00992) to HKD9.9
下一篇新聞︰11/02/2026 16:05 {I-bank focus}HSBC starts TravelSky Tech (00696) at HKD12.8
13/02/2026 16:07 {I-bank focus}UBS lowers Bud APAC (01876) to HKD8.6
11/02/2026 14:30 {I-bank focus}Daiwa raises Chow Tai Fook (01929) to HKD17
10/02/2026 16:02 {I-bank focus}HSBC lowers Pop Mart (09992) to HKD354
10/02/2026 14:50 {I-bank focus}HSBC raises Tigermed (03347) to HKD64.6
09/02/2026 16:07 {I-bank focus}HSBC raises Swire Properties (01972) to HKD30
